NCT02753764View on ClinicalTrials.gov

Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Corticosteroid Resistant (CR) Asthmatics
Interventions
DRUG

AZD7624

DRUG

prednisone

oral prednisone 20 mg bid for one week

DRUG

Placebo

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER

NCT02753764 - Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma | Biotech Hunter | Biotech Hunter